Deep Track Capital, LP - Jan 6, 2025 SCHEDULE 13G Report for Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value (GPCR)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value
Symbol
GPCR
Shares outstanding
172M shares
Disclosed Ownership
9M shares
Ownership
5.24%
Form type
SCHEDULE 13G
Date filed
1/13/2025, 04:08 PM
Date of event
Jan 6, 2025
Next filing
May 15, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 5.24% 9M 0 9M David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 5.24% 9M 0 9M David Kroin David Kroin, Director
David Kroin 5.24% 9M 0 9M David Kroin David Kroin